Page last updated: 2024-12-10

15-ketoprostaglandin f2alpha

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 15-ketoprostaglandin F2α (15-keto-PGF2α)

**15-keto-PGF2α** is a metabolite of **prostaglandin F2α (PGF2α)**, a hormone-like substance involved in various physiological processes, primarily in the reproductive system.

**Here's what makes it important for research:**

* **Marker of PGF2α activity:** 15-keto-PGF2α is a stable and readily detectable metabolite of PGF2α. Measuring its levels in various biological samples (urine, blood, etc.) can provide insights into the activity of PGF2α in the body.

* **Study of reproductive processes:** PGF2α plays a critical role in regulating uterine contractions, luteolysis (regression of the corpus luteum), and other reproductive functions. Studying 15-keto-PGF2α levels helps understand these processes and their potential dysfunctions.

* **Diagnosis and monitoring of diseases:** 15-keto-PGF2α levels are associated with several conditions like premature labor, menstrual disorders, and polycystic ovary syndrome. Monitoring these levels helps in diagnosis, treatment monitoring, and assessing the effectiveness of therapies.

* **Pharmacological research:** 15-keto-PGF2α serves as a tool for understanding the mechanisms of action of drugs targeting PGF2α pathways. This includes developing new drugs for contraception, treating reproductive disorders, and managing other medical conditions.

* **Animal studies:** 15-keto-PGF2α is used in animal studies to investigate reproductive physiology, especially in livestock breeding. This helps optimize breeding strategies and improve reproductive performance in animals.

**In summary, 15-keto-PGF2α serves as a valuable biomarker for research related to PGF2α activity, reproductive processes, and disease diagnostics. Its role in understanding PGF2α pathways and developing novel drugs further strengthens its significance in various research areas.**

Cross-References

ID SourceID
PubMed CID5280887
CHEBI ID28442
SCHEMBL ID11844030
MeSH IDM0087044

Synonyms (34)

Synonym
CHEBI:28442
35850-13-6
15-ketoprostaglandin f2alpha
(5z,13e)-9alpha,11alpha-dihydroxy-15-oxoprosta-5,13-dien-1-oic acid
15k-pgf2a
9s,11r-dihydroxy-15-oxo-5z,13e-prostadienoic acid
LMFA03010026
15-keto-prostaglandin f2alpha
15-keto-prostaglandin f2a
C05960
15-keto-pgf2a
15-keto-pgf2alpha
15-oxo pgf-2alpha
NCGC00161287-01
BML1-F12
(z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid
15-keto-prostaglandin f2 alpha
prosta-5,13-dien-1-oic acid, 9,11-dihydroxy-15-oxo-, (5z,9alpha,11alpha,13e)-
SCHEMBL11844030
9.alpha.,11.alpha.-dihydroxy-15-oxo-prosta-5z,13e-dien-1-oic acid
15-keto-prostaglandin f2.alpha.
HMS3648F08
15-oxo-prostaglandin f2alpha
15-keto pgf2alpha
Q27103699
sr-01000946495
SR-01000946495-1
(z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(z)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid
HY-113246
DTXSID801317581
15-keto prostaglandin f2alpha lipid maps(r) ms standard
PD020574
AKOS040756160
15-keto prostaglandin f2??
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
prostaglandins Falpha
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Eicosanoid metabolism via cyclooxygenases (COX)137
Arachidonic acid (AA, ARA) oxylipin metabolism076
Arachidonic acid metabolism via COX (Cyclooxygenase) pathway035

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (25.00)18.7374
1990's4 (10.00)18.2507
2000's21 (52.50)29.6817
2010's5 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.08 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (7.32%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (92.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]